These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12205076)

  • 1. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin.
    Betriu C; Culebras E; Redondo M; Rodríguez-Avial I; Gómez M; Boloix A; Picazo JJ
    J Antimicrob Chemother; 2002 Sep; 50(3):436-8. PubMed ID: 12205076
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
    Pavlovic L; Grego E; Sipetic-Grujicic S
    Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.
    Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
    Antimicrob Agents Chemother; 2002 Feb; 46(2):546-9. PubMed ID: 11796375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal spread of macrolide- and tetracycline-resistant [erm(A) tet(O)] emm77 Streptococcus pyogenes isolates in Italy and Norway.
    Palmieri C; Vecchi M; Littauer P; Sundsfjord A; Varaldo PE; Facinelli B
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4229-30. PubMed ID: 17043129
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
    Brandt CM; Honscha M; Truong ND; Holland R; Hövener B; Bryskier A; Lütticken R; Reinert RR
    Microb Drug Resist; 2001; 7(2):165-70. PubMed ID: 11442342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of tetracycline and macrolide resistance and emm characterization of Streptococcus pyogenes isolates in Tunisia.
    Hraoui M; Boutiba-Ben Boubaker I; Doloy A; Ben Redjeb S; Bouvet A
    Microb Drug Resist; 2011 Sep; 17(3):377-82. PubMed ID: 21612508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations.
    Farrell DJ; Shackcloth J; Barbadora KA; Green MD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):817-8. PubMed ID: 16436755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.
    Green M; Allen C; Bradley J; Dashefsky B; Gilsdorf JR; Marcon MJ; Schutze GE; Smith C; Walter E; Martin JM; Edwards KA; Barbadora KA; Rumbaugh RM; Wald ER
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2487-9. PubMed ID: 15917551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
    Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
    Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
    Katosova LK; Lazareva AV; Khokhlova TA; Ponomarenko OA; Alyabieva NM
    Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal dissemination of tetracycline resistance among Streptococcus pyogenes paediatric isolates from Brazil.
    Smeesters PR; Cadar S; Drèze PA; Campos D; Van Melderen L
    J Infect Dev Ctries; 2010 Nov; 4(11):704-11. PubMed ID: 21252447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.